Annie Marc

697 total citations
26 papers, 512 citations indexed

About

Annie Marc is a scholar working on Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Annie Marc has authored 26 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Biomedical Engineering and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Annie Marc's work include Viral Infectious Diseases and Gene Expression in Insects (19 papers), Protein purification and stability (9 papers) and 3D Printing in Biomedical Research (8 papers). Annie Marc is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (19 papers), Protein purification and stability (9 papers) and 3D Printing in Biomedical Research (8 papers). Annie Marc collaborates with scholars based in France, Italy and United Kingdom. Annie Marc's co-authors include Isabelle Chevalot, Lucía Monaco, Marco R. Soria, Nigel Jenkins, Jean‐Marc Engasser, Éric Olmos, Emmanuel Guédon, Marc Cherlet, Lorraine D. Buckberry and Bernard Meignier and has published in prestigious journals such as Biotechnology and Bioengineering, Journal of Theoretical Biology and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Annie Marc

26 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Marc France 14 399 110 88 80 59 26 512
Azam Rahimpour Iran 16 380 1.0× 62 0.6× 75 0.9× 138 1.7× 40 0.7× 45 666
Martí Lecina Spain 19 568 1.4× 280 2.5× 125 1.4× 37 0.5× 82 1.4× 48 772
Ji Yong Song South Korea 8 472 1.2× 77 0.7× 134 1.5× 102 1.3× 63 1.1× 10 566
Christian Leist Switzerland 15 574 1.4× 199 1.8× 152 1.7× 62 0.8× 28 0.5× 21 709
Johannes Fruehauf United States 12 559 1.4× 107 1.0× 166 1.9× 18 0.2× 135 2.3× 20 783
Jung Hoon Ahn South Korea 15 337 0.8× 50 0.5× 136 1.5× 24 0.3× 71 1.2× 25 586
Pamela K. Foreman United States 13 485 1.2× 306 2.8× 109 1.2× 42 0.5× 157 2.7× 21 803
Reinhard Waehler United States 10 544 1.4× 81 0.7× 403 4.6× 38 0.5× 58 1.0× 11 790
Pierre-Alain Ruffieux Switzerland 7 308 0.8× 184 1.7× 41 0.5× 49 0.6× 40 0.7× 8 400
Elisabetta Fortunati Italy 10 486 1.2× 41 0.4× 250 2.8× 19 0.2× 55 0.9× 18 697

Countries citing papers authored by Annie Marc

Since Specialization
Citations

This map shows the geographic impact of Annie Marc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Marc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Marc more than expected).

Fields of papers citing papers by Annie Marc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Marc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Marc. The network helps show where Annie Marc may publish in the future.

Co-authorship network of co-authors of Annie Marc

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Marc. A scholar is included among the top collaborators of Annie Marc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Marc. Annie Marc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akasov, Roman, Daria Zaytseva‐Zotova, Pavel S. Chelushkin, et al.. (2017). Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models. Advanced Pharmaceutical Bulletin. 7(4). 593–601. 16 indexed citations
2.
Guédon, Emmanuel, et al.. (2012). Limiting cell aggregation during mesenchymal stem cell expansion on microcarriers. Biotechnology Progress. 28(3). 780–787. 72 indexed citations
3.
Petiot, Emma, et al.. (2012). Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes. Cytotechnology. 64(4). 429–441. 17 indexed citations
4.
Mosser, Mathilde, Romain Kapel, Éric Olmos, et al.. (2012). Chromatographic fractionation of yeast extract: A strategy to identify physicochemical properties of compounds promoting CHO cell culture. Process Biochemistry. 47(7). 1178–1185. 9 indexed citations
5.
Petiot, Emma, et al.. (2010). In situ quantification of microcarrier animal cell cultures using near-infrared spectroscopy. Process Biochemistry. 45(11). 1832–1836. 12 indexed citations
6.
Chevalot, Isabelle, et al.. (2006). Peptide fractions of rapeseed hydrolysates as an alternative to animal proteins in CHO cell culture media. Process Biochemistry. 41(11). 2297–2304. 45 indexed citations
7.
Guillaume, Jean-Marc, et al.. (2004). HPCE Monitoring of the N-Glycosylation Pattern and Sialylation of Murine Erythropoietin Produced by CHO Cells in Batch Processes. Biotechnology Progress. 20(3). 864–871. 16 indexed citations
8.
Марквичева, Елена, Lina Bezdetnaya, Artur Bartkowiak, et al.. (2003). Encapsulated multicellular tumor spheroids as a novel in vitro model to study small size tumors. Hemijska industrija. 57(12). 585–588. 4 indexed citations
9.
Grégoire, Anne, Yanina N. Malykh, Athanase Visvikis, et al.. (2003). Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy. Biochimica et Biophysica Acta (BBA) - General Subjects. 1622(2). 133–144. 35 indexed citations
10.
Marc, Annie, et al.. (2003). Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium. Cytotechnology. 42(1). 1–11. 38 indexed citations
11.
Marvel, Jacqueline, et al.. (2001). Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free media. Cytotechnology. 35(2). 115–125. 24 indexed citations
12.
Bragonzi, Alessandra, Gianfranco Distefano, Lorraine D. Buckberry, et al.. (2000). A new Chinese hamster ovary cell line expressing α2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins. Biochimica et Biophysica Acta (BBA) - General Subjects. 1474(3). 273–282. 62 indexed citations
13.
Buckberry, Lorraine D., Lucía Monaco, Marco R. Soria, et al.. (1999). Na-butyrate increases the production and α2,6-sialylation of recombinant interferon-γ expressed by α2,6- sialyltransferase engineered CHO cells. Cytotechnology. 29(1). 55–64. 34 indexed citations
14.
Cherlet, Marc & Annie Marc. (1999). Hybridoma cell behaviour in continuous culture under hyperosmotic stress. Cytotechnology. 29(1). 71–84. 18 indexed citations
15.
Cherlet, Marc & Annie Marc. (1998). Intracellular pH Monitoring as a Tool for the Study of Hybridoma Cell Behavior in Batch and Continuous Bioreactor Cultures. Biotechnology Progress. 14(4). 626–638. 4 indexed citations
16.
Monaco, Lucía, Annie Marc, Alex Eon‐Duval, et al.. (1996). Genetic engineering of ?2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-?. Cytotechnology. 22(1-3). 197–203. 28 indexed citations
18.
Pons, Marie‐Noëlle, Anne Wagner, H. Vivier, & Annie Marc. (1992). Application of quantitative image analysis to a mammalian cell line grown on microcarriers. Biotechnology and Bioengineering. 40(1). 187–193. 20 indexed citations
19.
Martial, Adèle, et al.. (1991). Influence of inoculum age on hybridoma culture kinetics. Cytotechnology. 5(2). 165–171. 5 indexed citations
20.
Marc, Annie, Gérard Duc, Jean‐Marc Engasser, & Q.T. Nguyen. (1984). Réacteurs membranaires à enzymes immobilisées. Le Lait. 64(638-639). 239–251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026